FLGT – fulgent genetics, inc. (US:NASDAQ)
Stock Stats
News
Fulgent Genetics (NASDAQ:FLGT) was upgraded by analysts at Zacks Research from a "hold" rating to a "strong-buy" rating.
Fulgent Genetics to Acquire Bako Diagnostics Assets and StrataDx for $55.5 Million [Los Angeles Times (CA)]
Fulgent Genetics to buy Bako Diagnostics assets and StrataDx [Yahoo! Finance]
Fulgent Genetics Agrees to Acquire Bako Diagnostics and StrataDx [Yahoo! Finance]
Fulgent Genetics Agrees to Acquire Bako Diagnostics and StrataDx
Form 8-K Fulgent Genetics, Inc. For: Dec 20
Form 4 Fulgent Genetics, Inc. For: Dec 02 Filed by: Xie Jian
Form 4 Fulgent Genetics, Inc. For: Dec 01 Filed by: Kim Paul
Form 4 Fulgent Genetics, Inc. For: Dec 02 Filed by: Gao Hanlin
Form 4 Fulgent Genetics, Inc. For: Nov 28 Filed by: Xie Jian
Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies
If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.